tiprankstipranks
Calliditas Therapeutics (CALT)
NASDAQ:CALT

Calliditas Therapeutics (CALT) Stock Investors

120 Followers
Based on 746,050 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CALT
On average, investors allocate 0.00% of their portfolios to CALT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,050 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CALT

1.7%
Last 7
Days
5.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CALT, out of 746,050 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CALT Investor Activity

No data currently available
Based on the activity of 14,160 investors who made their portfolios public
The table shows changes in CALT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CALT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.66%
-0.07%
+2.27%
48.66B
Technology
DraftKings
5.81%
-0.98%
-1.43%
33.23B
Consumer Cyclical
ChargePoint Holdings
4.22%
-1.02%
-2.55%
935.67M
Consumer Cyclical
Airbnb
4.42%
-1.20%
+2.24%
94.53B
Consumer Cyclical
Block
4.21%
-0.90%
+0.36%
42.42B
Technology
Mercadolibre
5.28%
+0.39%
+2.51%
89.29B
Consumer Cyclical
Marathon Digital Holdings
5.57%
-0.98%
-0.18%
5.67B
Financial
Zscaler
3.87%
-0.42%
+3.29%
30.52B
Technology
Bristol-Myers Squibb
3.16%
-1.17%
+1.66%
82.02B
Healthcare
Celsius Holdings
4.57%
-0.30%
+3.18%
13.73B
Consumer Defensive
Based on the activity of 746,050 active portfolios
Open your Smart Portfolio

CALT Investor Analysis

CALT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.7%
of CALT holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
CALT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.0%
of CALT holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
CALT investors over 55

Over 55

3.3%
Last 30 days
Holdings Change
34.3%
of CALT holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of CALT stock investors
See who invests in CALT according to age group and performance.

FAQ

How many retail Investors hold CALT?
<0.1% of TipRanks' retail investors hold CALT in their portfolios.
    What is CALT Investor Sentiment?
    CALT’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CALT in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of CALT in the last 7 days.
        What percentage of retail investors changed their holding of CALT in the last 30 days?
        ▼ 5.1% of TipRanks' retail investors changed their holding of CALT in the last 30 days.
          What is the average age of retail investors who hold CALT?
          The average age of CALT Holders is between 35–55.
            What other stocks have CALT investors also bought?
            CALT Investors also bought TTD, DKNG, CHPT, ABNB, SQ, MELI, MARA, ZS, BMY, CELH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BSXBoston Scientific
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              HAEHaemonetics
              INSMInsmed
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis